The recent 8-1 decision expands the DOJ’s power to request such cases be thrown out.
Ruling could spell good news for labs and other healthcare providers targeted by whistleblowers in False Claims Act qui tam lawsuits.
Last week’s three key cases included two involving drug testing that was either medically unnecessary, or not provided at all.
A recent court case sheds some light on if denying employment can count as illegal remuneration under the Anti-Kickback Statute.
This model can help you create a whistleblower protection policy for your lab to encourage employees to voice their compliance concerns.